FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jörg Michael Schierholz

Research Profile

Chemicals & Drugs

Physiology

Bacterial Adhesions

Living Beings

Disorders

Phenomena

Equipment Contamination

Procedures

Devices

Indwelling Catheters

Co-author Network

Publications

TOP 3
Jörg Michael Schierholz; Klaus Nagelschmidt; Manfred Nagelschmidt; Rolf Lefering; Nedim Yücel; Josef Beuth
Antimicrobial central venous catheters in oncology: efficacy of a rifampicin-miconazole-releasing catheter.
Josef Beuth; B Schneider; Jörg Michael Schierholz
Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled multicenter comparative epidemiological cohort study.
Christian Morsczeck; Michael Korenkov; Manfred Nagelschmidt; Domonkos Feher; Jörg Michael Schierholz
Total RNA-isolation of abdominal hernia of rats for quantitative real-time reverse transcription (RT) PCR assays.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jörg Michael Schierholz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Jörg Michael Schierholz; Klaus Nagelschmidt; Manfred Nagelschmidt; Rolf Lefering; Nedim Yücel; Josef Beuth
Antimicrobial central venous catheters in oncology: efficacy of a rifampicin-miconazole-releasing catheter.
Anticancer research 2010;30(4):1353-8.
2008: Josef Beuth; B Schneider; Jörg Michael Schierholz
Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled multicenter comparative epidemiological cohort study.
Anticancer research 2008;28(1B):523-7.
2008: Christian Morsczeck; Michael Korenkov; Manfred Nagelschmidt; Domonkos Feher; Jörg Michael Schierholz
Total RNA-isolation of abdominal hernia of rats for quantitative real-time reverse transcription (RT) PCR assays.
Preparative biochemistry & biotechnology 2008;38(1):87-93.
2007: Arndt Büssing; Heidi Kochskämper; Sabine Rieger; Jörg Michael Schierholz; Dietrich Schlodder; Michael Schietzel
In vitro response of stimulated B-CLL lymphocytes of patients treated with Viscum album L. extracts.
Anticancer research 2007;27(6B):4195-200.
2007: Josef Beuth; Jörg Michael Schierholz
Review. Evidence-based complementary oncology. Innovative approaches to optimize standard therapy strategies.
In vivo (Athens, Greece) 2007;21(2):423-8.
2006: Josef Beuth; HL Ko; Hauke Schneider; Samir Tawadros; Hans-Udo Kasper; H Zimst; Jörg Michael Schierholz
Intratumoral application of standardized mistletoe extracts down regulates tumor weight via decreased cell proliferation, increased apoptosis and necrosis in a murine model.
Anticancer research 2006;26(6B):4451-6.
2006: Thomas Kälicke; Jörg Michael Schierholz; Urs Schlegel; Thomas M Frangen; Manfred Köller; Gert Printzen; Dominik Seybold; Stefan Klöckner; Gert Muhr; Stephan Arens
Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2006;24(8):1622-40.
2005: Christian Morsczeck; W Götz; Jörg Michael Schierholz; F Zeilhofer; U Kühn; Christoph Möhl; C Sippel; K H Hoffmann
Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth.
Matrix biology : journal of the International Society for Matrix Biology 2005;24(2):155-65.
2004: Nedim Yücel; Rolf Lefering; Marc Maegele; Martin Max; Rolf Rossaint; Andrea Koch; Rosemarie Schwarz; Michael Korenkov; Josef Beuth; Alfons Bach; Jörg Michael Schierholz; Gerhard Pulverer; Edmund A M Neugebauer
Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial.
The Journal of antimicrobial chemotherapy 2004;54(6):1109-15.
2004: Christian Morsczeck; Daniel Langendörfer; Jörg Michael Schierholz
A quantitative real-time PCR assay for the detection of tetR of Tn10 in Escherichia coli using SYBR Green and the Opticon.
Journal of biochemical and biophysical methods 2004;59(3):217-27.
2004: Jörg Michael Schierholz; Christian Morsczeck; N Brenner; D P König; Nedim Yücel; Michael Korenkov; E Neugebauer; A F E Rump; G Waalenkamp; Josef Beuth; Gerhard Pulverer; S Arens
[Special aspects of implant-associated infection in orthopedic surgery. From the pathophysiology to custom-tailored prevention strategies].
Der Orthopäde 2004;33(4):397-404.
2003: Michael Korenkov; Nedim Yücel; Jörg Michael Schierholz; P Goh; Hans Troidl
[Psoas abscesses. Genesis, diagnosis, and therapy].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2003;74(7):677-82.
2003: Michael Korenkov; Stefan Sauerland; Nedim Yücel; Lothar Köhler; P Goh; Jörg Michael Schierholz; Hans Troidl
Port function after laparoscopic adjustable gastric banding for morbid obesity.
Surgical endoscopy 2003;17(7):1068-71.
2003: A F E Rump; K Güttler; D P König; Nedim Yücel; Michael Korenkov; Jörg Michael Schierholz
Pharmacokinetics of the antimicrobial agents rifampicin and miconazole released from a loaded central venous catheter.
The Journal of hospital infection 2003;53(2):129-35.
2002: Jan Braun; HL Ko; Jörg Michael Schierholz; Josef Beuth
Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models.
Anticancer research 2002;22(6C):4187-90.
2002: Jörg Michael Schierholz; Nedim Yücel; A F E Rump; Josef Beuth; Gerhard Pulverer
Antiinfective and encrustation-inhibiting materials--myth and facts.
International journal of antimicrobial agents 2002;19(6):511-6.
2002: A F E Rump; Jörg Michael Schierholz; Wolfgang Klaus
Studies on the cardiotoxicity of noradrenaline in isolated rabbit hearts.
Arzneimittel-Forschung 2002;52(7):543-51.
2001: Jörg Michael Schierholz; Josef Beuth; A F E Rump; D P König; Gerhard Pulverer
Novel strategies to prevent catheter-associated infections in oncology patients.
Journal of chemotherapy (Florence, Italy) 2001;13 Spec No 1(1):239-50.
2001: A F E Rump; Jörg Michael Schierholz; W Biederbick; A E Koch; Wolfgang Klaus
Studies of the toxic effects of norepinephrine on isolated cardiomyocytes of guinea-pigs.
Arzneimittel-Forschung 2001;51(11):873-6.
2001: Jörg Michael Schierholz; Josef Beuth
Implant infections: a haven for opportunistic bacteria.
The Journal of hospital infection 2001;49(2):87-93.
2001: Jan Braun; HL Ko; Jörg Michael Schierholz; D Weir; C Caroline Blackwell; Josef Beuth
Application of standardized mistletoe extracts augment immune response and down regulates metastatic organ colonization in murine models.
Cancer letters 2001;170(1):25-31.
2001: Josef Beuth; Jörg Michael Schierholz; HL Ko; Jan Braun
Application-dependent immunomodulating and antimetastatic efficacy of thymic peptides in BALB/c-mice.
In vivo (Athens, Greece) 2001;15(5):403-6.
2001: Dietmar-Pierree König; Jörg Michael Schierholz; RD Hilgers; Christoph Bertram; Françoise Perdreau-Remington; Jürgen Rütt
In vitro adherence and accumulation of Staphylococcus epidermidis RP 62 A and Staphylococcus epidermidis M7 on four different bone cements.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2001;386(5):328-32.
2001: Dietmar-Pierree König; Jörg Michael Schierholz; Uwe Münnich; Jürgen Rütt
Treatment of staphylococcal implant infection with rifampicin-ciprofloxacin in stable implants.
Archives of orthopaedic and trauma surgery 2001;121(5):297-9.
2001: A F E Rump; Jörg Michael Schierholz; Renate Rösen; K Güttler; Wolfgang Klaus
Studies on the role of superoxide anion radicals for the cardiotoxicity of adrenochrome.
Arzneimittel-Forschung 2001;51(12):964-70.
2000: Josef Beuth; Jörg Michael Schierholz; G Mayer; Y Keisari
Thymic humoral factor-gamma 2 augments immune cell response and exerts antitumor activity in murine model systems.
Anticancer research 2000;20(6B):4473-6.
2000: Josef Beuth; Jörg Michael Schierholz; G Mayer
Thymosin alpha(1) application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice.
Cancer letters 2000;159(1):9-13.
2000: Jörg Michael Schierholz; C Fleck; Josef Beuth; Gerhard Pulverer
The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity.
The Journal of antimicrobial chemotherapy 2000;46(1):45-50.
2000: D Lenartz; U Dott; J Menzel; Jörg Michael Schierholz; Josef Beuth
Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe.
Anticancer research 2000;20(3B):2073-6.
2000: Jörg Michael Schierholz; Josef Beuth
Sophisticated medical devices as local drug-delivery systems.
Medical device technology 2000;11(2):12-4, 16-7.
2000: Jörg Michael Schierholz; Josef Beuth; Gerhard Pulverer
Evidence for a self-fulfilling hypothesis: chlorhexidine dressing for reduction of microbial colonization of the skin with central venous catheters.
The Journal of hospital infection 2000;44(3):241-3.
2000: Jörg Michael Schierholz; A Bach; C Fleck; Josef Beuth; D König; Gerhard Pulverer
Measurement of ultrasonic-induced chlorhexidine liberation: correlation of the activity of chlorhexidine-silver-sulfadiazine-impregnated catheters to agar roll technique and broth culture.
The Journal of hospital infection 2000;44(2):141-5.
2000: Jörg Michael Schierholz; Rolf Lefering; E Neugebauer; Josef Beuth; D P König; Gerhard Pulverer
Central venous catheters and bloodstream infection.
JAMA : the journal of the American Medical Association 2000;283(4):477-8; author reply 478-9.
2000: Jörg Michael Schierholz; Josef Beuth; Gerhard Pulverer
"Difficult to treat infections" pharmacokinetic and pharmacodynamic factors--a review.
Acta microbiologica et immunologica Hungarica 2000;47(1):1-8.
2000: D P König; Jörg Michael Schierholz; C H Bertram
Decreased accumulation of S. epidermidis RP 62 A on to stainless steel in comparison with other biomaterials.
The Journal of hospital infection 2000;44(1):75-6.
1999: Jörg Michael Schierholz; Josef Beuth; Gerhard Pulverer; D P König
Silver-containing polymers.
Antimicrobial agents and chemotherapy 1999;43(11):2819-20; author reply 2820-1.
1999: Jörg Michael Schierholz; Josef Beuth; Gerhard Pulverer; D P König
The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection.
The American journal of medicine 1999;107(5):534-5.
1999: Josef Beuth; Jörg Michael Schierholz; G Mayer
Immunomodulating and antimetastatic activity of thymic peptides in BALB/c mice.
Anticancer research 1999;19(4B):2993-5.
1999: Dietmar-Pierree König; Françoise Perdreau-Remington; Jürgen Rütt; RD Hilgers; Jörg Michael Schierholz
Adherence to and accumulation of S. epidermidis on different biomaterials due to extracellular slime production. In vitro comparison of a slime-producing strain (Rp 62 A) and its isogenic slime negative mutant (M7).
Zentralblatt für Bakteriologie : international journal of medical microbiology 1999;289(3):355-64.
1999: Jörg Michael Schierholz; Josef Beuth; Gerhard Pulverer
Silver coating of medical devices for catheter-associated infections?
The American journal of medicine 1999;107(1):101-2.
1999: Jörg Michael Schierholz; Josef Beuth; Gerhard Pulverer
The quantity and duration of the antimicrobial efficacy of a chlorhexidine and silversulfadiazine impregnated catheter.
The Journal of hospital infection 1999;42(2):163-5.
1999: Jörg Michael Schierholz; D P König; Josef Beuth; Gerhard Pulverer
The myth of encrustation inhibiting materials.
The Journal of hospital infection 1999;42(2):162-3.
1999: Jörg Michael Schierholz; Josef Beuth; Dietmar-Pierree König; A Nürnberger; Gerhard Pulverer
Antimicrobial substances and effects on sessile bacteria.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1999;289(2):165-77.
1999: Jörg Michael Schierholz; Josef Beuth; Gerhard Pulverer
Adherent bacteria and activity of antibiotics.
The Journal of antimicrobial chemotherapy 1999;43(1):158-60.
1999: A F E Rump; Jörg Michael Schierholz; W Biederbick; Martin Theisohn; Christoph Diefenbach; M Abel; Ulf Börner; Walter Buzello; Wolfgang Klaus
Pseudocholinesterase-activity reduction during cardiopulmonary bypass: the role of dilutional processes and pharmacological agents.
General pharmacology 1999;32(1):65-9.
1998: Jörg Michael Schierholz; Josef Beuth; Gerhard Pulverer
Killing effects of antibiotics and two-fold antimicrobial combinations on proliferating and non growing staphylococci.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1998;288(4):527-39.
1998: Jörg Michael Schierholz; L J Lucas; A F E Rump; Gerhard Pulverer
Efficacy of silver-coated medical devices.
The Journal of hospital infection 1998;40(4):257-62.
1998: Jörg Michael Schierholz; Gerhard Pulverer
Investigation of a rifampin, fusidic-acid and mupirocin releasing silicone catheter.
Biomaterials 1998;19(22):2065-74.
1998: A F E Rump; Jörg Michael Schierholz; Wolfgang Klaus
Studies of the cardioprotective effects of ascorbic acid in isolated rabbit hearts.
Arzneimittel-Forschung 1998;48(11):1078-82.
1998: Jörg Michael Schierholz; A F E Rump; Gerhard Pulverer; Josef Beuth
Anti-infective catheters: novel strategies to prevent nosocomial infections in oncology.
Anticancer research 1998;18(5B):3629-38.
1998: Jörg Michael Schierholz; Z Wachol-Drewek; L J Lucas; Gerhard Pulverer
Activity of silver ions in different media.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1998;287(4):411-20.
1997: Jörg Michael Schierholz; Gerhard Pulverer
Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1997;286(1):107-23.
1997: Jörg Michael Schierholz; H Steinhauser; A F E Rump; Reinhard Berkels; Gerhard Pulverer
Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features.
Biomaterials 1997;18(12):839-44.
1997: Jörg Michael Schierholz; A F E Rump; Gerhard Pulverer
[Clinical and preclinical efficacy of antimicrobial catheters].
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 1997;32(5):298-305.
1997: Jörg Michael Schierholz
Physico-chemical properties of a rifampicin-releasing polydimethylsiloxane shunt.
Biomaterials 1997;18(8):635-41.
1997: Jörg Michael Schierholz; A F E Rump; Gerhard Pulverer
New antiinfectious biomaterials. Ciprofloxacin containing polyurethanes as potential drug delivery systems to prevent foreign-body infections.
Arzneimittel-Forschung 1997;47(1):70-4.
1996: Jörg Michael Schierholz; A F E Rump; Gerhard Pulverer
Drug delivery concepts for the efficacious prevention of foreign-body infections.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1996;284(2-3):390-401.
1996: A F E Rump; S Botvinik-Helling; Martin Theisohn; W Biederbick; Jörg Michael Schierholz; M Stemmler; Roman Fischbach; Walter Heindel; Klaus Lackner; Wolfgang Klaus
Pharmacokinetics of intraarterial mitomycin C in the chemoembolisation treatment of liver metastases.
General pharmacology 1996;27(4):669-71.
1995: A F E Rump; W Biederbick; S Botvinik-Helling; M Stemmler; Jörg Michael Schierholz; S Conrady; Bärbel Matthey; Martin Theisohn; Michael Diestelhorst; Günter K Krieglstein
Mitomycin-C concentration in human ocular aqueous humor after topical administration during trabeculectomy.
Arzneimittel-Forschung 1995;45(12):1329-30.
1995: JA Hampl; Jörg Michael Schierholz; B Jansen; Alfred Aschoff
In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections.
Acta neurochirurgica 1995;133(3-4):147-52.
1994: Jörg Michael Schierholz; B Jansen; Lothar Jaenicke; Gerhard Pulverer
In-vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection.
Biomaterials 1994;15(12):996-1000.